NID1 and breast cancer: Analysis of additional markers of EMT [4] revealed that breast cancer samples with high PEAK1 levels expressed reduced levels of the epithelial markers MUC1, E-Cadherin and Entactin and increased levels of the mesenchymal markers Syndecan1 and LEF1 (S1A Fig).